| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $50K | — | +0.0% |
| R&D Expense | $3.6M | — | -52.3% |
| SG&A Expense | $2.2M | — | -6.3% |
| Operating Income | -$5.8M | — | +41.3% |
| Net Income | -$5.4M | — | +44.5% |
| EPS (Basic) | -$0.20 | — | +53.5% |
| EPS (Diluted) | -$0.20 | — | +53.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $479K | -88.8% | -62.7% |
| Current Assets | $22.8M | -23.6% | +8.9% |
| Total Assets | $25.8M | -20.2% | -31.7% |
| Current Liabilities | $5.4M | -36.0% | -32.0% |
| Total Liabilities | $6.2M | -29.8% | -23.8% |
| Stockholders' Equity | $19.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.4M | — | +50.1% |
| Financing Cash Flow | $5.3M | — | +0.0% |
| -33.9% |